Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Quest Diagnostics Raises FY2025 Adj EPS Guidance from $9.63-$9.83 to $9.76-$9.84 vs $9.75 Est; Raises FY2025 Sales Guidance from $10.800B-$10.920B to $10.960B-$11.000B vs $10.865B Est

Author: Benzinga Newsdesk | October 21, 2025 05:47am
Quest Diagnostics (NYSE:DGX) raises FY2025 Adj EPS guidance from $9.63-$9.83 to $9.76-$9.84 vs $9.75 analyst estimate. Raises FY2025 sales outlook from $10.800 billion-$10.920 billion to $10.960 billion-$11.000 billion vs $10.865 billion estimate.

Posted In: DGX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist